Warning: The NCBI web site requires JavaScript to function. more...
Unité de phénotypage et thérapie moléculaire, Hôpital ophtalmique universitaire Jules-Gonin, 1004 Lausanne. h.tran@ucl.ac.uk
Recently, preliminary results of three clinical gene therapy trials for early onset retinitis pigmentosa--Leber congenital amaurosis--suggested that treating this degenerative retinal disease by gene transfection can be safe and efficient to restore a visual function. The definitive validation of this therapeutic approach depends on the long-term results. The forthcoming availability of gene therapy in ophthalmology prompts the implementation: of 1) recruitment, 2) phenotyping and genotyping of affected patients, 3) and creation of a hereditary retinopathy registry.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on